Do Antihistamines Really Stop Working Over Time?

A patient wrote to the Asthma and Allergy Foundation of America's Ask the Allergist service this year with a complaint that will sound familiar to anyone on daily allergy medication: six years of Zyrtec, taken every day for chronic hives, and the drug seemed to be losing its grip.

The allergist's answer was direct.

"Patients taking antihistamines such as Zyrtec for a long time (months to years), may develop a tolerance to these medicines. The effects of the medicine to control your symptoms are not as good as when you first started it."

Dr. John M. James, board-certified allergist, AAFA Ask the Allergist

His advice: increase the dose or stop for three to 14 days, then restart, or switch to a different antihistamine.

Cross the Atlantic and ask the same question of the UK's National Institute for Health and Care Excellence, and the answer flips. Guidance summarized by pharmacist-reviewed clinical resources holds that there is no solid clinical evidence that true pharmacological tolerance develops with regular use of second-generation antihistamines such as cetirizine, loratadine, or fexofenadine, and NICE does not recommend rotating antihistamines to prevent it.

Can you build a tolerance to antihistamines?

The honest answer is that the science is unsettled, and the two camps are talking about different things. Older, sedating antihistamines, chlorphenamine and diphenhydramine, better known as Benadryl, show measurable tolerance to their sedative effects within days, a pattern documented in pharmacology going back to the 1950s. What's contested is whether the newer, non-sedating generation loses its allergy-blocking power the same way.

Studies have not demonstrated significant downregulation of the H1 histamine receptor in response to long-term use of second-generation antihistamines. Receptor downregulation is the textbook mechanism behind tolerance to drugs like opioids and benzodiazepines. Without it, there's no clean biological explanation for why a pill that worked in year one should stop working in year four.

Why does allergy medicine feel weaker after years of use?

If the receptors aren't changing, something else is. Three explanations do most of the work. Allergen exposure can climb over time: a new pet, a move to a pollen-heavy region, a house that develops a dust mite problem. Pollen counts also vary year to year, so a medication dose calibrated for a mild season can feel outmatched in a heavy one. And dosing timing matters more than most patients realize. Antihistamines work better started before exposure begins, not after symptoms have already flared.

There's a fourth possibility that's easy to miss. Some people develop new sensitivities to allergens they weren't previously reactive to. That's not the medication failing. It's the immune system finding a new target.

What should you do if your antihistamine stops working?

Switching between second-generation antihistamines, cetirizine to loratadine, say, is a reasonable first move, since individual response varies for reasons researchers don't fully understand. Adding an intranasal corticosteroid spray, now widely available over the counter, is generally considered more effective than an oral antihistamine alone for nasal symptoms. What clinicians on both sides of the debate agree on: don't stack more than one oral antihistamine without medical advice, and don't exceed the labeled dose hoping to force a response.

For genuinely persistent cases, the six-year hives, not a bad ragweed August, the conversation shifts away from antihistamines altogether. Chronic spontaneous urticaria, hives with no identifiable trigger lasting more than six weeks, sometimes calls for a biologic like omalizumab, sold as Xolair, which targets the antibody driving the allergic response rather than blocking histamine after the fact. Allergen immunotherapy, the gradual desensitization shots or sublingual tablets that retrain the immune system rather than suppress its output, remains the only treatment that changes the underlying allergic response instead of managing it, and it has to be started and supervised by a specialist.

None of this resolves the argument between the allergist fielding six years of hives questions and the guideline writers reading receptor studies. It does narrow what's worth doing about it: track when symptoms actually got worse, rule out a changed environment or a missed dose window first, and treat "my allergy pill quit on me" as a prompt to ask a pharmacist or allergist rather than a verdict to self-diagnose.